The aim of the current study was to prospectively survey the factors related to achieving an EULAR good/remission using the DAS-28 disease activity score and investigate predictors of a sustained response in a population of biologic naïve patients with refractory rheumatoid arthritis who receive tumor necrosis factor inhibitors TNF-I. Here, TNF is linked to rheumatoid arthritis.